Clinical Trial

Reactive Driven Support for Treatment, Adherence, Resilience, and Thriving (reSTART) Clinical Trial

Study acronym: reSTART
Recruiting
View on ClinicalTrials.gov →
Summary
Men who are living with HIV and use stimulants face many challenges and barriers that may interfere with remembering to take their HIV medication. Forgetting to take HIV medication puts men living with HIV at a greater risk of becoming virally unsuppressed. Researchers are doing this study to test if a remote intervention can help participants improve remembering to take their HIV medications and reduce the HIV viral load among men living with HIV who use stimulants.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-08-07; most recent amendment 2026-03-11.
Status change: Not Yet Recruiting → Recruiting 2026-03-04
Trial Details
NCT Number NCT07125235
Lead Sponsor University of California, San Francisco
Collaborators: Florida International University, San Diego State University, National Institute on Drug Abuse (NIDA)
Conditions Behavioral Intervention, Viral Suppression of HIV Infection, ART Adherence
Enrollment 270 participants
Start Date 2026-02-09
Primary Completion 2028-04-30 (estimated)
Study Completion 2028-07-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-13